OGEN Oragenics Inc

0.1999 (6.8%)
Last Updated: 12:27:08
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 1,263
Bid Price
Ask Price
News -
Day High 3.14


52 Week Range


Day Low 2.94
Company Name Stock Ticker Symbol Market Type
Oragenics Inc OGEN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1999 6.8% 3.1399 12:27:08
Open Price Low Price High Price Close Price Prev Close
2.94 2.94 3.14 2.94
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
54 1,263 $ 3.14 $ 3,962 - 2.58 - 17.40
Last Trade Time Type Quantity Stock Price Currency
12:29:10 8 $ 2.94 USD

Oragenics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.97M - - - -261.38
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Oragenics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No OGEN Message Board. Create One! See More Posts on OGEN Message Board See More Message Board Posts

Historical OGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.893.22652.752.884,3540.24998.65%
1 Month3.633.6352.753.135,526-0.4901-13.5%
3 Months3.334.482.653.5310,616-0.1901-5.71%
6 Months3.074.482.583.3410,2130.06992.28%
1 Year14.29817.402.589.32238,943-11.16-78.04%
3 Years33.03108.002.5848.403,870,836-29.89-90.49%
5 Years83.40224.402.5855.193,504,870-80.26-96.24%

Oragenics Description

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and having other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now